Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Breast Cancer
100%
Overall Survival
75%
Neoplasm
55%
Recurrent Disease
51%
Adjuvant Chemoradiotherapy
42%
Bile Duct Cancer
41%
Prognostic Factor
39%
Extrahepatic Bile Duct
38%
Disease Free Survival
37%
Quadrantectomy
37%
Survival Rate
36%
Retrospective Study
30%
Lymph Node
29%
Adjuvant Radiotherapy
28%
Mastectomy
26%
Distant Metastasis Free Survival
20%
Neoadjuvant Chemotherapy
20%
Multivariate Analysis
18%
Brain Metastasis
18%
Distant Metastasis
17%
Breast Radiotherapy
17%
Median Follow Up
17%
Surgical Margin
17%
Hazard Ratio
17%
Hepatocellular Carcinoma
15%
Local Recurrence Free Survival
14%
Intensity Modulated Radiation Therapy
13%
Whole Brain Radiotherapy
12%
Lymph Node Metastasis
12%
Fluorouracil
12%
Recurrence Free Survival
12%
Cholangiocarcinoma
10%
Treatment Outcome
10%
Pelvis
9%
Systemic Therapy
9%
Adjuvant Chemotherapy
9%
Tumor
9%
Adjuvant Therapy
9%
Supraclavicular Lymph Node
8%
Meta-Analysis
8%
Volumetric Modulated Arc Therapy
8%
Propensity Score Matching
8%
Adenocarcinoma
8%
Intraductal Carcinoma
8%
Malignant Neoplasm
8%
Lymph Node Irradiation
8%
Pancreaticoduodenectomy
7%
Surveillance, Epidemiology, and End Results
7%
Progression Free Survival
7%
Carcinoembryonic Antigen
7%
Phyllodes Tumor
7%
Squamous Cell Carcinoma
7%
Minimal Residual Disease
7%
Pancreas Cancer
7%
Gamma Urogastrone
6%
Epidermal Growth Factor Receptor 2
6%
Conservative Treatment
6%
Cervical Cancer
6%
Internal Mammary Lymph Node
6%
Axillary Lymph Node
6%
Thoracic Wall
6%
Recurrence Risk
6%
Magnetic Resonance Imaging
6%
Breast Tumor
5%
Survivin
5%
Ampulla of Vater
5%
Biological Marker
5%
Cancer Specific Survival
5%
Retroperitoneal Lymph Node Dissection
5%
Risk Stratification
5%
Arm
5%
Internal Mammary Node
5%
Tumor Infiltrating Lymphocyte
5%
Metastatic Carcinoma
5%
Medical Record
5%
Pharmacology, Toxicology and Pharmaceutical Science
Overall Survival
24%
Neoplasm
23%
Recurrent Disease
16%
Survival Rate
13%
Breast Cancer
13%
Bile Duct Cancer
12%
Fluorouracil
9%
Distant Metastasis Free Survival
8%
Disease Free Survival
8%
Chemotherapy Regimens
7%
Distant Metastasis
6%
Local Recurrence Free Survival
5%
Lymph Node Metastasis
5%